BIB

Investor Moves

Name	Value	Action	Change	Price	Current Price
Ken GriffinCitadel Advisors $-390.9K ExitQ1 2026 $391k -- $84.84
Ken GriffinCitadel Advisors $-807.8K ExitQ2 2025 $808k -- $84.84
Ken GriffinCitadel Advisors $-807.8K ExitQ2 2025 $808k -- $84.84
Ken GriffinCitadel Advisors $124.7K AddQ1 2025 $125k -- $84.84
Ken GriffinCitadel Advisors $124.7K AddQ1 2025 $125k -- $84.84
Ken GriffinCitadel Advisors $186.3K AddQ4 2024 $186k -- $84.84

News

defenseworld.netProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Price Cross Below 50 Day Moving Average – What’s Next?defenseworld.netMar 20

Trade BIB

About ProShares - Ultra Nasdaq Biotechnology

The ProShares Ultra Nasdaq Biotechnology fund is structured to provide daily investment returns that effectively magnify the daily performance of the Nasdaq Biotechnology Index by two hundred percent (2x), all measured before accounting for any associated fees and expenses.

IPO Date: Apr 9, 2010

Market Data

Open: $86.72
High: $86.72
Low: $83.23
Volume: 11.3K
Avg Volume: 9.4K
52W High: $90.91
52W Low: $44.20

Valuation

Market Cap: $74M
Dividend Yield: 49.3%

Financials

Financial statement snapshot is not available yet.

Events

DividendMar 25

$0.00714